Aran Research & Development (1982) (XTAE:ARAN) Research & Development: ₪0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ARAN Aran Research & Development (1982) Ltd XTAE:ARAN
78 GF Score
Price ₪39.78
GF Value ₪37.11
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Aran Research & Development (1982) Research & Development?

Aran Research & Development (1982) XTAE:ARAN +1.20% 78 Research & Development is ₪0.0 Mil as of Dec. 2025. GuruFocus rates XTAE:ARAN with a GF Score™ of 78/100 and a GF Value™ of ₪37.11 (Fairly Valued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Aran Research & Development (1982)'s Research & Development for the six months ended in Dec. 2025 was ₪0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was ₪0.0 Mil.

Aran Research & Development (1982)  (XTAE:ARAN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aran Research & Development (1982) Research & Development Related Terms

Aran Research & Development (1982) Research & Development Historical Data

* Premium members only.

The historical data trend for Aran Research & Development (1982)'s Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aran Research & Development (1982) Research & Development Chart

Aran Research & Development (1982) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aran Research & Development (1982) Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XTAE:ARAN
78GF Score
Aran Research & Development (1982) Ltd XTAE:ARAN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aran Research & Development (1982) Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₪0.0 Mil mean?
Aran Research & Development (1982) (XTAE:ARAN) has a Research & Development of ₪0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Aran Research & Development (1982) and its competitors.
Is Aran Research & Development (1982)'s Research & Development too high?
Aran Research & Development (1982)'s current Research & Development is ₪0.0 Mil. Overall, Aran Research & Development (1982) has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aran Research & Development (1982)'s Research & Development compare to MMM and HON?
Aran Research & Development (1982)'s Research & Development of ₪0.0 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Conglomerates company?
A good Research & Development depends on the Conglomerates industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aran Research & Development (1982) and its competitors. Aran Research & Development (1982)'s current Research & Development is ₪0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aran Research & Development (1982) stock overvalued right now?
Based on GuruFocus' analysis, Aran Research & Development (1982) (XTAE:ARAN) is currently considered Fairly Valued. The stock's GF Value™ is ₪37.11, compared to a current price of ₪39.78 — trading 7.2% above its estimated fair value. The current Research & Development is ₪0.0 Mil. Aran Research & Development (1982)'s overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aran Research & Development (1982) (XTAE:ARAN), the current Research & Development is ₪0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aran Research & Development (1982) (XTAE:ARAN) Overvalued in 2026?

Based on GuruFocus' analysis, Aran Research & Development (1982) stock appears to be overvalued. The current stock price of ₪39.78 is trading 7.2% above its estimated GF Value™ of ₪37.11. GuruFocus considers Aran Research & Development (1982) to be Fairly Valued.

Key valuation signals for XTAE:ARAN:

  • Research & Development: ₪0.0 Mil
  • GF Value™: ₪37.11 vs. price of ₪39.78 (7.2% above fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the XTAE:ARAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aran Research & Development (1982) Business Description

Address 43 HaEshel Street, P.O.B 3067, Caesarea Business Park, Tel Aviv, ISR, 3088900
Aran Research & Development (1982) Ltd is a product design and development company. It also manufactures equipment for the plastics industry. It develops & supplies products including medical devices, water, defense & HLS, consumer & industrial and injection molds. It also has medical startups which focuses on Cardiovascular, Laparoscopy and Gastrointestinal endoscopy.
78GF Score

Get the complete analysis for XTAE:ARAN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪39.78
Price
₪37.11
GF Value